Stay updated on Pembrolizumab + Imprime PGG in NSCLC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab + Imprime PGG in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab + Imprime PGG in NSCLC Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    Revision: v3.5.4 was added and v3.5.3 was deleted, indicating a page version update.
    Difference
    0.0%
    Check dated 2026-05-16T09:24:59.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    Change Detected
    Summary
    The page’s UI/version marker was bumped from “v3.5.2” to “v3.5.3,” indicating a site revision update rather than a change to the clinical study information.
    Difference
    0.0%
    Check dated 2026-04-25T05:22:46.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    Page revision updated from v3.5.0 to v3.5.2.
    Difference
    0.0%
    Check dated 2026-04-18T03:27:37.000Z thumbnail image
  6. Check
    58 days ago
    Change Detected
    Summary
    Revision tag updated to v3.5.0. The previous revision v3.4.3 was removed.
    Difference
    0.0%
    Check dated 2026-03-20T03:27:18.000Z thumbnail image
  7. Check
    65 days ago
    Change Detected
    Summary
    Revision: v3.4.3 was added and Revision: v3.4.2 was removed from the page's revision history.
    Difference
    0.0%
    Check dated 2026-03-12T20:27:08.000Z thumbnail image
  8. Check
    94 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.4.2 (replacing Revision: v3.4.1). To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-12T01:42:07.000Z thumbnail image

Stay in the know with updates to Pembrolizumab + Imprime PGG in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab + Imprime PGG in NSCLC Clinical Trial page.